Why does the clinic refer to Lyme disease as the Lyme Borreliosis Complex (LBC)?


Dr. Jemsek coined “Lyme Borreliosis Complex” years ago, and it is now a widely used term throughout the Lyme medical community. To fully understand the term, it helps to break it down word-for-word. “Lyme” is the common name for Borrelia, which is the type of bacteria that causes the infection. “Borreliosis” refers to the actual infection itself. “Complex” refers to the group of other infections or microbes that contribute to symptoms. Lyme/ Borrelia (being the causative agent) results in, for lack of a better phrase, “immune confusion” which allows these other infections to proliferate. These can be other tick-borne diseases that would not normally result in exacerbated symptoms or communicable diseases. However, these infections get picked up and become part of our normal biome due to the “immune confusion.” In the grand scheme of things, the terms “Lyme disease”, “Borreliosis”, or even “tickborne disease” do not encompass the vast variety of infectious microbes and genetic and immunologic factors that result in symptoms—hence, the need for the coined term.

Why is this important?

There is overall an inadequate degree of understanding of this disease process preventing many clinicians from recognizing or even doing an appropriate work-up regarding LBC. Essentially, a full, thorough physical exam and history is imperative in order to determine the multiple factors that can indicate LBC. In addition, it helps us rule out other etiologies and make changes to medications, supplementation, and interventions that may be more effective at improving a person’s quality of life. Many providers have become so specialized that looking at the entire patient is not seen as their job and therefore the patient becomes a “problem” or sent off to the next specialist who has his/her niche area in which the LBC patient will likely not fit. This situation occurs when a provider is looking at the patient with a limited view of the causative agent and not a broader view of kamagra. Treatments then are implemented with a limited view of the problem.

The real dilemma is the inadequate amount of time providers have with a patient. The face-to-face time has been cut so short that it is difficult to even properly treat one problem let alone the complex and chronically ill. The concern isn’t necessarily an ignorance of LBC but the complete compartmentalization of the patient. In medicine, there is a theory that many symptoms are likely due to one cause as opposed to several different etiologies, yet in our technologically advanced world we have archaically changed this stance—ultimately seeing complex patients as a problem, not trying to find a solution. Looking at Lyme disease rightfully so as a complex will spare providers today, and into the future, a myopic view of the problem, and will facilitate quicker positive outcomes for patients.